FDA Inspection 1171011 — Central Pennsylvania Blood Bank
The FDA completed an inspection of Central Pennsylvania Blood Bank on May 6, 2022 in Hershey, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 6, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hershey, PA (United States)